Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

8,439 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,769
Recruiting: 1,009
Ph III recruiting: 99
Growth YoY: −2.8%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.6%
Trials / 1,000 deaths: 75 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,350)

clinicaltrialsPublishedShowing 1,301–1,350 of 1,576 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00003406	Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer	completed	Phase 1 / Phase 2	30	Cancer Treatment Centers of AmericaOTHER	1	Mar 26, 2013	clinicaltrials
NCT00003408	Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer	completed	Phase 2	40	Cancer Treatment Centers of AmericaOTHER	1	Mar 26, 2013